Optimind Pharma Corp. (CSE:OMND)

Market Cap	515.74K
Revenue (ttm)	121.29K +2.5%
Net Income	-117.94K
EPS	-0.00
Shares Out	103.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,000
Open	0.0050
Previous Close	0.0100
Day's Range	0.0050 - 0.0050
52-Week Range	0.0050 - 0.0100
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 3, 2026

About Optimind Pharma

Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities. It also provides cannabis referrals. In addition, the company operates clinics. Optimind Pharma Corp. is headquartered in Toronto, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: David Goodman
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OMND

Financial Performance

In fiscal year 2026, Optimind Pharma's revenue was 121,293, an increase of 2.47% compared to the previous year's 118,368. Losses were -117,935, -45.35% less than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 9, 2026

Data Sources Report a data error